Emerging concepts in liquid biopsies

S Perakis, MR Speicher - BMC medicine, 2017 - Springer
Characterizing and monitoring tumor genomes with blood samples could achieve significant
improvements in precision medicine. As tumors shed parts of themselves into the circulation …

The potential of liquid biopsies for the early detection of cancer

E Heitzer, S Perakis, JB Geigl, MR Speicher - NPJ precision oncology, 2017 - nature.com
Precision medicine refers to the choosing of targeted therapies based on genetic data. Due
to the increasing availability of data from large-scale tumor genome sequencing projects …

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death

H Hieronymus, R Murali, A Tin, K Yadav, W Abida… - Elife, 2018 - elifesciences.org
The level of copy number alteration (CNA), termed CNA burden, in the tumor genome is
associated with recurrence of primary prostate cancer. Whether CNA burden is associated …

Inferring expressed genes by whole-genome sequencing of plasma DNA

P Ulz, GG Thallinger, M Auer, R Graf, K Kashofer… - Nature …, 2016 - nature.com
The analysis of cell-free DNA (cfDNA) in plasma represents a rapidly advancing field in
medicine. cfDNA consists predominantly of nucleosome-protected DNA shed into the …

Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs

RT Todd, A Selmecki - Elife, 2020 - elifesciences.org
Previously, we identified long repeat sequences that are frequently associated with genome
rearrangements, including copy number variation (CNV), in many diverse isolates of the …

Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma

P Jiang, K Sun, YK Tong, SH Cheng… - Proceedings of the …, 2018 - National Acad Sciences
Circulating tumor-derived cell-free DNA (ctDNA) analysis offers an attractive noninvasive
means for detection and monitoring of cancers. Evidence for the presence of cancer is …

Precision oncology in the age of integrative genomics

C Kumar-Sinha, AM Chinnaiyan - Nature biotechnology, 2018 - nature.com
Precision oncology applies genomic and other molecular analyses of tumor biopsies to
improve the diagnosis and treatment of cancers. In addition to identifying therapeutic …

Single-molecule sequencing enables long cell-free DNA detection and direct methylation analysis for cancer patients

LYL Choy, W Peng, P Jiang, SH Cheng… - Clinical …, 2022 - academic.oup.com
Background Analysis of circulating tumor DNA has become increasingly important as a tool
for cancer care. However, the focus of previous studies has been on short fragments of DNA …

Circulating tumor DNA: an emerging tool in gastrointestinal cancers

OB Alese, N Cook, A Ortega-Franco, MB Ulanja, L Tan… - 2022 - christie.openrepository.com
Circulating tumor DNA (ctDNA) is tumor-derived fragmented DNA in the bloodstream that
has come from primary or metastatic cancer sites. Neoplasm-specific genetic and epigenetic …

Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients

N Van Roy, M Van Der Linden, B Menten… - Clinical Cancer …, 2017 - AACR
Purpose: Neuroblastoma (NB) is a heterogeneous disease characterized by distinct clinical
features and by the presence of typical copy-number alterations (CNAs). Given the strong …